A Phase IV, Prospective, Open-label, Multicentre, Single Arm, 3-month Proof of Concept Study to Assess the Effect of IKERVIS® Eye Drops Administered Once Daily on the Quality of Vision in Dry Eye Disease (DED) Patients With Severe Keratitis
Phase of Trial: Phase IV
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Ciclosporin (Primary)
- Indications Dry eyes
- Focus Proof of concept; Therapeutic Use
- Sponsors Santen S.A.S.
- 04 Oct 2017 Planned End Date changed from 1 Jan 2018 to 1 Jul 2018.
- 04 Oct 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Jul 2018.
- 12 Jan 2017 New trial record